Applicants,Chemical_Name,Funding_requested_for,Pharmaceutical,Priority_List,Schedules,Therapeutic_group
Clinician,Sofosbuvir,"Hepatitis C, second-line treatment in combination with glecaprevir and pibrentasvir after prior direct-acting antiviral treatment",Sofosbuvir,Recommended for decline,,
